A detailed history of Oppenheimer Asset Management Inc. transactions in Embecta Corp. stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 10,638 shares of EMBC stock, worth $114,358. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,638
Previous 11,004 3.33%
Holding current value
$114,358
Previous $140,000 26.43%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 31, 2025

SELL
$9.28 - $13.3 $3,396 - $4,867
-366 Reduced 3.33%
10,638 $103,000
Q1 2025

Apr 22, 2025

BUY
$12.28 - $20.93 $11,137 - $18,983
907 Added 8.98%
11,004 $140,000
Q4 2024

Feb 04, 2025

BUY
$12.51 - $20.83 $126,313 - $210,320
10,097 New
10,097 $209,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $622M
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Oppenheimer Asset Management Inc. Portfolio

Follow Oppenheimer Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.